Back to Journals » Cancer Management and Research » Volume 12

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]

Authors Li D, Cheng X, Zheng W, Chen J

Received 23 July 2020

Accepted for publication 23 July 2020

Published 5 August 2020 Volume 2020:12 Pages 6861—6862

DOI https://doi.org/10.2147/CMAR.S273562


Li D, Cheng X, Zheng W, Chen J. Cancer Manag Res. 2020;12:4923–4935.

The authors have advised Figure 5E on page 4931 is incorrect. Due to an error at the time of figure assembly shGNPDA1-1 and shGNPDA1-2 in the SMMC-7721 column were duplicated. The correct Figure 5 is shown below.

The authors apologize for this error and advise it does not affect the results of the paper.


Read the original article

Li D, Cheng X, Zheng W, Chen J. Cancer Manag Res. 2020;12:4923–4935.

The authors have advised Figure 5E on page 4931 is incorrect. Due to an error at the time of figure assembly shGNPDA1-1 and shGNPDA1-2 in the SMMC-7721 column were duplicated. The correct Figure 5 is shown below.

Figure 5 GNPDA1 enhances cell proliferation. (A) Results of the MTT assay performed in SMMC-7721 and Huh7 cells with GNPDA1 knockdown and controls. (B) Representative images of the cell cycle analysis. (C) GNPDA1 knockdown induced G0/G1 arrest. (D) Representative images of the EdU proliferation assay. (E) Quantification of EdU-positive cells (n = 3). *P < 0.05, **P < 0.01, and ***P < 0.001. Abbreviations: shctrl, the control cell line of cell line with low GNPDA1; shGNPDA1-1, Cell line numbered 1 with low GNPDA1; shGNPDA1-2, Cell line numbered 2 with low GNPDA1; GNPDA1, glucosamine-6-phosphate isomerase 1.

The authors apologize for this error and advise it does not affect the results of the paper.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]